Susan Moore1. 1. CancerExpertise, Chicago, IL 60641-3228, USA. susan.moore@cancerexpertise.com
Abstract
OBJECTIVES: To compare and contrast the side-effect profiles of antineoplastic therapy options used in the treatment of metastatic breast cancer. DATA SOURCES: Published research articles, abstracts, and clinical experience. CONCLUSION: Novel and existing antineoplastic agents used in the treatment of metastatic breast cancer generally have mild side effects, but can have the potential for serious reactions. Nausea/vomiting, diarrhea, stomatitis/mucositis, and dermatologic and cardiovascular effects are common. Strategies such as dietary changes, over-the-counter remedies, and dose modification can be used to counteract these mild effects. IMPLICATIONS FOR NURSING PRACTICE: The oncology nurse should be aware of common adverse events associated with antineoplastic agents, recognize early side-effect signs, and be ready with effective strategies to mitigate side effects when and if they occur.
OBJECTIVES: To compare and contrast the side-effect profiles of antineoplastic therapy options used in the treatment of metastatic breast cancer. DATA SOURCES: Published research articles, abstracts, and clinical experience. CONCLUSION: Novel and existing antineoplastic agents used in the treatment of metastatic breast cancer generally have mild side effects, but can have the potential for serious reactions. Nausea/vomiting, diarrhea, stomatitis/mucositis, and dermatologic and cardiovascular effects are common. Strategies such as dietary changes, over-the-counter remedies, and dose modification can be used to counteract these mild effects. IMPLICATIONS FOR NURSING PRACTICE: The oncology nurse should be aware of common adverse events associated with antineoplastic agents, recognize early side-effect signs, and be ready with effective strategies to mitigate side effects when and if they occur.
Authors: Amanda Digel Vandyk; Margaret B Harrison; Gail Macartney; Amanda Ross-White; Dawn Stacey Journal: Support Care Cancer Date: 2012-04-17 Impact factor: 3.603
Authors: Rebecca M Speck; Angela DeMichele; John T Farrar; Sean Hennessy; Jun J Mao; Margaret G Stineman; Frances K Barg Journal: Support Care Cancer Date: 2012-01-11 Impact factor: 3.603
Authors: Christine K Zoon; Elizabeth Q Starker; Arianne M Wilson; Michael R Emmert-Buck; Steven K Libutti; Michael A Tangrea Journal: Expert Rev Mol Diagn Date: 2009-07 Impact factor: 5.225
Authors: Murali M Yallapu; Shadi F Othman; Evan T Curtis; Nichole A Bauer; Neeraj Chauhan; Deepak Kumar; Meena Jaggi; Subhash C Chauhan Journal: Int J Nanomedicine Date: 2012-04-17
Authors: René-Jean Bensadoun; Phillipe Humbert; Jean Krutman; Thomas Luger; Raoul Triller; André Rougier; Sophie Seite; Brigitte Dreno Journal: Cancer Manag Res Date: 2013-12-09 Impact factor: 3.989
Authors: B Dreno; R J Bensadoun; P Humbert; J Krutmann; T Luger; R Triller; A Rougier; S Seité Journal: J Eur Acad Dermatol Venereol Date: 2013-02-01 Impact factor: 6.166